For brothers Malvinder and Shivinder Singh who, in 2008, sold their stake in Ranbaxy Laboratories to Japanese pharma company Daiichi Sankyo for $4.1 billion in a blockbuster deal, life seems to have come full circle.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
